-
1
-
-
0032621222
-
Use of alternative therapies among breast cancer outpatients compared with the general population
-
VandeCreek L, Rogers E, Lester J. Use of alternative therapies among breast cancer outpatients compared with the general population. Altern Ther Health Med 1999;5:71-76.
-
(1999)
Altern Ther Health Med
, vol.5
, pp. 71-76
-
-
VandeCreek, L.1
Rogers, E.2
Lester, J.3
-
2
-
-
0031772908
-
Cancer chemoprevention part 1: Retinoids and carotenoids and other classic antioxidants
-
Singh DK, Lippman SM. Cancer chemoprevention part 1: retinoids and carotenoids and other classic antioxidants. Oncology 1998;12:1643-1660.
-
(1998)
Oncology
, vol.12
, pp. 1643-1660
-
-
Singh, D.K.1
Lippman, S.M.2
-
3
-
-
0032986046
-
High doses of multiple antioxidant vitamins: Essential ingredients in improving the efficacy of standard cancer therapy
-
Prasad KN, Kumar A, Kochupillai V, Cole WC. High doses of multiple antioxidant vitamins: essential ingredients in improving the efficacy of standard cancer therapy. J Am Coll Nutr 1999;18:13-25.
-
(1999)
J Am Coll Nutr
, vol.18
, pp. 13-25
-
-
Prasad, K.N.1
Kumar, A.2
Kochupillai, V.3
Cole, W.C.4
-
4
-
-
0030684743
-
Free radicals and antioxidants in chemotherapy induced toxicity
-
Weijl NI, Cleton FJ, Osanto S. Free radicals and antioxidants in chemotherapy induced toxicity. Cancer Treat Rev 1997;23:209-240.
-
(1997)
Cancer Treat Rev
, vol.23
, pp. 209-240
-
-
Weijl, N.I.1
Cleton, F.J.2
Osanto, S.3
-
5
-
-
0032805202
-
Possible interactions between dietary antioxidants and chemotherapy
-
Labriola D, Livingston R. Possible interactions between dietary antioxidants and chemotherapy. Oncology 1999;13:1003-1012.
-
(1999)
Oncology
, vol.13
, pp. 1003-1012
-
-
Labriola, D.1
Livingston, R.2
-
6
-
-
0032962588
-
Apoptosis and therapy
-
Schmitt CA, Lowe SW. Apoptosis and therapy. J Pathol 1999;187:127-137.
-
(1999)
J Pathol
, vol.187
, pp. 127-137
-
-
Schmitt, C.A.1
Lowe, S.W.2
-
7
-
-
0030663670
-
Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: A p53-independent induction of p21 via C/EBP-beta
-
Chinery R, Brockman JA, Peeler MO, et al. Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21 via C/EBP-beta. Nat Med 1997;3:1233-1241.
-
(1997)
Nat Med
, vol.3
, pp. 1233-1241
-
-
Chinery, R.1
Brockman, J.A.2
Peeler, M.O.3
-
8
-
-
0033580776
-
Melatonin increases p53 and p21 WAF1 expression in MCF-7 human breast cancer cells ib vitro
-
Mediavilla MD, Cos S, Sanchez-Barcelo EJ. Melatonin increases p53 and p21 WAF1 expression in MCF-7 human breast cancer cells ib vitro. Life Sci 1999;65:415-420.
-
(1999)
Life Sci
, vol.65
, pp. 415-420
-
-
Mediavilla, M.D.1
Cos, S.2
Sanchez-Barcelo, E.J.3
-
9
-
-
0002586648
-
Vitamin A and beta-carotene as adjunctive therapy to tumour excision, radiation therapy and chemotherapy
-
Prasad K, ed. New York: Karger Press
-
Seifter E, Rettura G, Padawer J. Vitamin A and beta-carotene as adjunctive therapy to tumour excision, radiation therapy and chemotherapy. In Prasad K, ed. Vitamins Nutrition and Cancer. New York: Karger Press; 1984:2-19.
-
(1984)
Vitamins Nutrition and Cancer
, pp. 2-19
-
-
Seifter, E.1
Rettura, G.2
Padawer, J.3
-
10
-
-
0019196549
-
Advanced recurrent squamous cell carcinoma of the head and neck
-
Thatcher N, Blackledge G, Crowther D. Advanced recurrent squamous cell carcinoma of the head and neck. Cancer 1980;46:1324-1328.
-
(1980)
Cancer
, vol.46
, pp. 1324-1328
-
-
Thatcher, N.1
Blackledge, G.2
Crowther, D.3
-
12
-
-
0023618556
-
Nontoxic potentiation of cancer chemotherapy by combined C and K3 vitamin pre-treatment
-
Taper HS, de Gerlache J, Lans M, et al. Nontoxic potentiation of cancer chemotherapy by combined C and K3 vitamin pre-treatment. Int J Cancer 1987;40:575-579.
-
(1987)
Int J Cancer
, vol.40
, pp. 575-579
-
-
Taper, H.S.1
De Gerlache, J.2
Lans, M.3
-
13
-
-
0023709436
-
Combined effects of vitamin E (alpha-tocopherol) and cisplatin on the growth of murine neuroblastoma in vivo
-
Sue K, Nakagawara A, Okuzono SI, et al. Combined effects of vitamin E (alpha-tocopherol) and cisplatin on the growth of murine neuroblastoma in vivo. Eur J Cancer Clin Oncol 1988;24:1751-1758.
-
(1988)
Eur J Cancer Clin Oncol
, vol.24
, pp. 1751-1758
-
-
Sue, K.1
Nakagawara, A.2
Okuzono, S.I.3
-
14
-
-
0017656527
-
Adriamycin: The role of lipid peroxidation in cardiac toxicity and tumor response
-
Myers CE, McGuire WP, Liss RH, et al. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science 1977;197:165-167.
-
(1977)
Science
, vol.197
, pp. 165-167
-
-
Myers, C.E.1
McGuire, W.P.2
Liss, R.H.3
-
15
-
-
0021272431
-
Effect of selenite on renal toxicity and antitumor activity of cis-diamminedichloroplatinum in mice inoculated with ehrlich ascites tumor cell
-
Naganuma A, Satoh M, Imura N. Effect of selenite on renal toxicity and antitumor activity of cis-diamminedichloroplatinum in mice inoculated with ehrlich ascites tumor cell. J Pharm Dyn 1984;7:217-220.
-
(1984)
J Pharm Dyn
, vol.7
, pp. 217-220
-
-
Naganuma, A.1
Satoh, M.2
Imura, N.3
-
16
-
-
0021270562
-
Effect of selenium in combination with cis-diamminedichloroplatinum(II) in the treatment of murine fibrosarcoma
-
Berry JP, Pauwella C, Tlouzeau S, et al. Effect of selenium in combination with cis-diamminedichloroplatinum(II) in the treatment of murine fibrosarcoma. Cancer Res 1984;44:2864-2868.
-
(1984)
Cancer Res
, vol.44
, pp. 2864-2868
-
-
Berry, J.P.1
Pauwella, C.2
Tlouzeau, S.3
-
17
-
-
0026742912
-
Treatment with antioxidant and other nutrients in combination with chemotherapy and irradiation in patients with small-cell lung cancer
-
Jaakkola K, Lahteenmaki P, Laakso J, et al. Treatment with antioxidant and other nutrients in combination with chemotherapy and irradiation in patients with small-cell lung cancer. Anticancer Res 1992;12:599-606.
-
(1992)
Anticancer Res
, vol.12
, pp. 599-606
-
-
Jaakkola, K.1
Lahteenmaki, P.2
Laakso, J.3
-
18
-
-
0031202122
-
A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state
-
Lissoni P, Paolorossi F, Ardizzoia A. A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state. J Pineal Res 1997;23:15-19.
-
(1997)
J Pineal Res
, vol.23
, pp. 15-19
-
-
Lissoni, P.1
Paolorossi, F.2
Ardizzoia, A.3
-
19
-
-
0028937541
-
Modulation of cancer endocrine therapy by melatonin: A phase II study on tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone
-
Lissoni P, Barni S, Meregalli S, et al. Modulation of cancer endocrine therapy by melatonin: a phase II study on tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone. Br J Cancer 1995;71:854-856.
-
(1995)
Br J Cancer
, vol.71
, pp. 854-856
-
-
Lissoni, P.1
Barni, S.2
Meregalli, S.3
-
20
-
-
0033007460
-
Vitamin and calcium supplement use is associated with decrease adenoma recurrence in patients with a previous history of neoplasia
-
Whelan RL, Horvath KD, Gleason NR, et al. Vitamin and calcium supplement use is associated with decrease adenoma recurrence in patients with a previous history of neoplasia. Dis Colon Rectum 1999;42:212-217.
-
(1999)
Dis Colon Rectum
, vol.42
, pp. 212-217
-
-
Whelan, R.L.1
Horvath, K.D.2
Gleason, N.R.3
-
21
-
-
0028085182
-
Megadose vitamins in bladder cancer: A double-blind clinical trial
-
Lamm DL, Riggs DR, Shriver JS, et al. Megadose vitamins in bladder cancer: a double-blind clinical trial. J Urol 1994;151:21-26.
-
(1994)
J Urol
, vol.151
, pp. 21-26
-
-
Lamm, D.L.1
Riggs, D.R.2
Shriver, J.S.3
-
22
-
-
0025177045
-
The effect of quercetin on cell cycle progression and growth of human gastric cancer cells
-
Yoshida M, Sakai T, Hosokawa N, et al. The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett 1990;260:10-13.
-
(1990)
FEBS Lett
, vol.260
, pp. 10-13
-
-
Yoshida, M.1
Sakai, T.2
Hosokawa, N.3
-
25
-
-
0029823128
-
Treatment of unresectable recurrent head and neck carcinoma with 13-cis-retinoic acid and interferon-alpha. A phase II study
-
Nikolaou AC, Fountazilas G, Daniilidis I. Treatment of unresectable recurrent head and neck carcinoma with 13-cis-retinoic acid and interferon-alpha. A phase II study. J Laryngol Orol 1996;110:857-861.
-
(1996)
J Laryngol Orol
, vol.110
, pp. 857-861
-
-
Nikolaou, A.C.1
Fountazilas, G.2
Daniilidis, I.3
-
26
-
-
0024423303
-
Retinoic acid therapy for promyelocytic leukemia
-
Chomienne C, Ballerini P, Balitrand N, et al. Retinoic acid therapy for promyelocytic leukemia. Lancet 1989;2:746-747.
-
(1989)
Lancet
, vol.2
, pp. 746-747
-
-
Chomienne, C.1
Ballerini, P.2
Balitrand, N.3
-
27
-
-
0025882306
-
Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)
-
Warrell RP, Frankel SR, Miller WH, et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 1991;324:1385-1393.
-
(1991)
N Engl J Med
, vol.324
, pp. 1385-1393
-
-
Warrell, R.P.1
Frankel, S.R.2
Miller, W.H.3
-
28
-
-
0023752982
-
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
-
Meng-er H, Yu-chen Y, Shu-rong C, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988;72:567-572.
-
(1988)
Blood
, vol.72
, pp. 567-572
-
-
Meng-er, H.1
Yu-chen, Y.2
Shu-rong, C.3
-
29
-
-
0025201879
-
All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical Results
-
Castaigne S, Chomienne C, Daniel MT, et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical Results. Blood 1990;76:1704-1709.
-
(1990)
Blood
, vol.76
, pp. 1704-1709
-
-
Castaigne, S.1
Chomienne, C.2
Daniel, M.T.3
-
30
-
-
0001679798
-
Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid
-
Breitman TR, Selonick SE, Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci 1980;77:2936-2940.
-
(1980)
Proc Natl Acad Sci
, vol.77
, pp. 2936-2940
-
-
Breitman, T.R.1
Selonick, S.E.2
Collins, S.J.3
-
31
-
-
0021055035
-
A phase I trial of beta-all-trans-retinoic acid delivered via a collagen sponge and a cervical cap for mild or moderate intraepithelial cervical neoplasia
-
Meyskens FL, Graham V, Chvapil M, et al. A phase I trial of beta-all-trans-retinoic acid delivered via a collagen sponge and a cervical cap for mild or moderate intraepithelial cervical neoplasia. J Natl Cancer Inst 1983;71:921-925.
-
(1983)
J Natl Cancer Inst
, vol.71
, pp. 921-925
-
-
Meyskens, F.L.1
Graham, V.2
Chvapil, M.3
-
32
-
-
0028343678
-
Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: A randomized trial
-
Meyskens FL, Surwit E, Moon TE, et al. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J Natl Cancer Inst 1994;86:539-543.
-
(1994)
J Natl Cancer Inst
, vol.86
, pp. 539-543
-
-
Meyskens, F.L.1
Surwit, E.2
Moon, T.E.3
-
33
-
-
0025091456
-
Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck
-
Hong WK, Lippman SM, Itri LM, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990;323:795-801.
-
(1990)
N Engl J Med
, vol.323
, pp. 795-801
-
-
Hong, W.K.1
Lippman, S.M.2
Itri, L.M.3
-
34
-
-
0024367957
-
Differentiation of human variant small cell lung cancer cell lines to a classic morphology by retinoic acid
-
Doyle LA, Giangiulo D, Hussain A. Differentiation of human variant small cell lung cancer cell lines to a classic morphology by retinoic acid. Cancer Res 1989;49:6745-6751.
-
(1989)
Cancer Res
, vol.49
, pp. 6745-6751
-
-
Doyle, L.A.1
Giangiulo, D.2
Hussain, A.3
-
35
-
-
0027207575
-
Adjuvant treatment of stage I lung cancer with high-dose vitamin A
-
Pastorino U, Infante M, Maioli M, et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993;11:1216-1222.
-
(1993)
J Clin Oncol
, vol.11
, pp. 1216-1222
-
-
Pastorino, U.1
Infante, M.2
Maioli, M.3
-
36
-
-
0023518660
-
Phase II study of isotretinoin in the treatment of advanced non-small cell lung cancer
-
Grunberg SM, Itri LM. Phase II study of isotretinoin in the treatment of advanced non-small cell lung cancer. Cancer Treat Rep 1987;71:1097-1098.
-
(1987)
Cancer Treat Rep
, vol.71
, pp. 1097-1098
-
-
Grunberg, S.M.1
Itri, L.M.2
-
37
-
-
0028019882
-
Randomized trial of vitamin A versus observation as adjuvant therapy in high-risk primary malignant melanoma: A Southwest Oncology Group study
-
Meyskens FL, Tuthill RJ, Sondak VK, et al. Randomized trial of vitamin A versus observation as adjuvant therapy in high-risk primary malignant melanoma: a Southwest Oncology Group study. J Clin Oncol 1994;12:2060-2065.
-
(1994)
J Clin Oncol
, vol.12
, pp. 2060-2065
-
-
Meyskens, F.L.1
Tuthill, R.J.2
Sondak, V.K.3
-
38
-
-
0032862848
-
Phase II study of all-trans retinoic acid administered intermittently for hormone refractory prostate cancer
-
Culine S, Kramar A, Droz JP, Theodore C. Phase II study of all-trans retinoic acid administered intermittently for hormone refractory prostate cancer. J Urol 1999;161:173-175.
-
(1999)
J Urol
, vol.161
, pp. 173-175
-
-
Culine, S.1
Kramar, A.2
Droz, J.P.3
Theodore, C.4
-
39
-
-
0022547707
-
Vitamin A, carotenoids, and retinoids
-
Hennekens CH, Mayrent SL, Willett W. Vitamin A, carotenoids, and retinoids. Cancer 1986;58:1837-1841.
-
(1986)
Cancer
, vol.58
, pp. 1837-1841
-
-
Hennekens, C.H.1
Mayrent, S.L.2
Willett, W.3
-
40
-
-
0024438841
-
Inhibitory effects of alpha-carotene on proliferation of the human neuroblastoma cell line GOTO
-
Murakoshi M, Takayasu J, Kimura O, et al. Inhibitory effects of alpha-carotene on proliferation of the human neuroblastoma cell line GOTO. J Natl Cancer Inst 1989;81:1649-1652.
-
(1989)
J Natl Cancer Inst
, vol.81
, pp. 1649-1652
-
-
Murakoshi, M.1
Takayasu, J.2
Kimura, O.3
-
41
-
-
0010607277
-
The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers
-
The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-1035.
-
(1994)
N Engl J Med
, vol.330
, pp. 1029-1035
-
-
-
42
-
-
0345157579
-
Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease
-
Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-1149.
-
(1996)
N Engl J Med
, vol.334
, pp. 1145-1149
-
-
Hennekens, C.H.1
Buring, J.E.2
Manson, J.E.3
-
43
-
-
0033559952
-
Lower prostate cancer risk in men with elevated plasma lycopene levels: Results of a prospective analysis
-
Gann PH, Ma J, Giovannucci E, et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 1999;59:1225-1230.
-
(1999)
Cancer Res
, vol.59
, pp. 1225-1230
-
-
Gann, P.H.1
Ma, J.2
Giovannucci, E.3
-
44
-
-
0033008852
-
Lycopene and 1,25-dihyroxyvitamin D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells
-
Amir H, Karas M, Giat J, et al. Lycopene and 1,25-dihyroxyvitamin D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells. Nutr Cancer 1999;33:105-112.
-
(1999)
Nutr Cancer
, vol.33
, pp. 105-112
-
-
Amir, H.1
Karas, M.2
Giat, J.3
-
45
-
-
0028863013
-
Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene
-
Levy J, Bosin E, Feldman B, et al. Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene. Nutr Cancer 1995;24:257-266.
-
(1995)
Nutr Cancer
, vol.24
, pp. 257-266
-
-
Levy, J.1
Bosin, E.2
Feldman, B.3
-
46
-
-
0028832890
-
Reversible changes in radiation response induced by all-trans retinoic acid
-
Duchesne GM, Hutchinson LK. Reversible changes in radiation response induced by all-trans retinoic acid. Int J Radiat Oncol Biol Phys 1995;33:875-880.
-
(1995)
Int J Radiat Oncol Biol Phys
, vol.33
, pp. 875-880
-
-
Duchesne, G.M.1
Hutchinson, L.K.2
-
47
-
-
0031964864
-
Interferon-alpha 2a, 13-cis-retinoic acid and radiotherapy for locally advanced carcinoma of the cervix: A pilot study
-
Park TK, Lee JP, Kim SN, et al. Interferon-alpha 2a, 13-cis-retinoic acid and radiotherapy for locally advanced carcinoma of the cervix: a pilot study. Eur J Gynaecol Oncol 1998;19:35-38.
-
(1998)
Eur J Gynaecol Oncol
, vol.19
, pp. 35-38
-
-
Park, T.K.1
Lee, J.P.2
Kim, S.N.3
-
48
-
-
0015305947
-
Vitamin A and the radiation response of experimental tumors: An immune mediated effect
-
Tannock IF, Suit HD, Marshall N. Vitamin A and the radiation response of experimental tumors: an immune mediated effect. J Natl Cancer Inst 1972;48:731-741.
-
(1972)
J Natl Cancer Inst
, vol.48
, pp. 731-741
-
-
Tannock, I.F.1
Suit, H.D.2
Marshall, N.3
-
49
-
-
0023888189
-
The modifying effect of beta-carotene on radiation and chemotherapy induced oral mucositis
-
Mills EED. The modifying effect of beta-carotene on radiation and chemotherapy induced oral mucositis. Br J Cancer 1988;57:416-417.
-
(1988)
Br J Cancer
, vol.57
, pp. 416-417
-
-
Mills, E.E.D.1
-
50
-
-
0028172581
-
Effects of retinoids, beta-carotene, and canthaxanthin on UV- And X-ray induced transformation of C3H10T1/2 cells in vitro
-
Kennedy AR, Krinsky NI. Effects of retinoids, beta-carotene, and canthaxanthin on UV- and X-ray induced transformation of C3H10T1/2 cells in vitro. Nutr Cancer 1994;22:219-232.
-
(1994)
Nutr Cancer
, vol.22
, pp. 219-232
-
-
Kennedy, A.R.1
Krinsky, N.I.2
-
51
-
-
0024367957
-
Differentiation of human variant small cell lung cancer cell lines to a classic morphology by retinoic acid
-
Doyle LA, Giangiulo D, Hussain A. Differentiation of human variant small cell lung cancer cell lines to a classic morphology by retinoic acid. Cancer Res 1989;49:6745-6751.
-
(1989)
Cancer Res
, vol.49
, pp. 6745-6751
-
-
Doyle, L.A.1
Giangiulo, D.2
Hussain, A.3
-
52
-
-
0026354558
-
Differential response of retinoic acid pretreated human synovial sarcoma cell line to anticancer drugs
-
Adwankar M, Banerji A, Ghosh S. Differential response of retinoic acid pretreated human synovial sarcoma cell line to anticancer drugs. Tumori 1991;77:391-394.
-
(1991)
Tumori
, vol.77
, pp. 391-394
-
-
Adwankar, M.1
Banerji, A.2
Ghosh, S.3
-
53
-
-
0027201741
-
Vitamin A, a useful biochemical modulator capable of preventing intestinal damage during methotrexate treatment
-
Nagai Y, Horie T, Awazu S. Vitamin A, a useful biochemical modulator capable of preventing intestinal damage during methotrexate treatment. Pharmacol Toxicol 1993;73:69-74.
-
(1993)
Pharmacol Toxicol
, vol.73
, pp. 69-74
-
-
Nagai, Y.1
Horie, T.2
Awazu, S.3
-
54
-
-
0031948025
-
Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism
-
Weisman RA, Christen R, Los G, et al. Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism. Otolaryngol Head Neck Surg 1998;118:597-602.
-
(1998)
Otolaryngol Head Neck Surg
, vol.118
, pp. 597-602
-
-
Weisman, R.A.1
Christen, R.2
Los, G.3
-
55
-
-
0032530604
-
A phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma
-
Kalemkerian GP, Jiroutek M, Ettinger DS, et al. A phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma. Cancer 1998;83:1102-1108.
-
(1998)
Cancer
, vol.83
, pp. 1102-1108
-
-
Kalemkerian, G.P.1
Jiroutek, M.2
Ettinger, D.S.3
-
56
-
-
0031814703
-
Advanced carcinoma of the pancreas: Phase II study of combined chemotherapy, beta-interferon, and retinoids
-
Recchia F, Sica G, Casucci D, et al. Advanced carcinoma of the pancreas: phase II study of combined chemotherapy, beta-interferon, and retinoids. Am J Clin Oncol 1998;21:275-278.
-
(1998)
Am J Clin Oncol
, vol.21
, pp. 275-278
-
-
Recchia, F.1
Sica, G.2
Casucci, D.3
-
57
-
-
0025914075
-
Pharmacological studies of retinol palmitate and its clinical effect in patients with acute non-lymphocytic leukemia
-
Tsutani H, Ueda T, Uchida M, Nakamura T. Pharmacological studies of retinol palmitate and its clinical effect in patients with acute non-lymphocytic leukemia. Leukemia Res 1991;15:463-471.
-
(1991)
Leukemia Res
, vol.15
, pp. 463-471
-
-
Tsutani, H.1
Ueda, T.2
Uchida, M.3
Nakamura, T.4
-
59
-
-
0006171777
-
Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer
-
Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer. Proc Natl Acad Sci 1976;73:3685-3689.
-
(1976)
Proc Natl Acad Sci
, vol.73
, pp. 3685-3689
-
-
Cameron, E.1
Pauling, L.2
-
60
-
-
0026326616
-
Protocol for the use of vitamin C in the treatment of cancer
-
Cameron E. Protocol for the use of vitamin C in the treatment of cancer. Med Hypothesis 1991;36:190-194.
-
(1991)
Med Hypothesis
, vol.36
, pp. 190-194
-
-
Cameron, E.1
-
61
-
-
0018669229
-
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer: A controlled trial
-
Creagan ET, Moertel CG, O'Fallon JR, et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer: a controlled trial. N Engl J Med 1979;301:687-690.
-
(1979)
N Engl J Med
, vol.301
, pp. 687-690
-
-
Creagan, E.T.1
Moertel, C.G.2
O'Fallon, J.R.3
-
62
-
-
0021955675
-
High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy
-
Moertel CG, Fleming TR, Creagan ET, et al. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. N Engl J Med 1985;312:137-141.
-
(1985)
N Engl J Med
, vol.312
, pp. 137-141
-
-
Moertel, C.G.1
Fleming, T.R.2
Creagan, E.T.3
-
63
-
-
0031836272
-
High-dose intravenous vitamin C in the treatment of a patient with renal cell carcinoma of the kidney
-
Riordan HD, Jackson JA, Riordan NH, Schultz M. High-dose intravenous vitamin C in the treatment of a patient with renal cell carcinoma of the kidney. J Orthomol Med 1998;13:72-73.
-
(1998)
J Orthomol Med
, vol.13
, pp. 72-73
-
-
Riordan, H.D.1
Jackson, J.A.2
Riordan, N.H.3
Schultz, M.4
-
64
-
-
0028925925
-
Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent
-
Riordan NH, Riordan HD, Meng X, et al. Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent. Med Hypotheses 1995;44:207-213.
-
(1995)
Med Hypotheses
, vol.44
, pp. 207-213
-
-
Riordan, N.H.1
Riordan, H.D.2
Meng, X.3
-
65
-
-
0023062974
-
Safety of high-level vitamin C ingestion
-
Rivers JM. Safety of high-level vitamin C ingestion. Ann NY Acad Sci 1988;498:445-454.
-
(1988)
Ann NY Acad Sci
, vol.498
, pp. 445-454
-
-
Rivers, J.M.1
-
66
-
-
0016275402
-
The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer
-
Cameron E, Campbell A. The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem Biol Interactions 1974;9:285-315.
-
(1974)
Chem Biol Interactions
, vol.9
, pp. 285-315
-
-
Cameron, E.1
Campbell, A.2
-
67
-
-
0017657479
-
The relationship between cancer, radiotherapy and vitamin C
-
Kakar SC, Wilson CWM, Moriarty MJ. The relationship between cancer, radiotherapy and vitamin C. Ir J Med Sci 1977;146:289-294.
-
(1977)
Ir J Med Sci
, vol.146
, pp. 289-294
-
-
Kakar, S.C.1
Wilson, C.W.M.2
Moriarty, M.J.3
-
68
-
-
0030005062
-
Potentiation of radiotherapy by nontoxic pretreatment with combined vitamins C and K3 in mice bearing solid transplantable tumor
-
Taper HS, Keyeux A, Roberfroid M. Potentiation of radiotherapy by nontoxic pretreatment with combined vitamins C and K3 in mice bearing solid transplantable tumor. Anticancer Res 1996;16:499-504.
-
(1996)
Anticancer Res
, vol.16
, pp. 499-504
-
-
Taper, H.S.1
Keyeux, A.2
Roberfroid, M.3
-
69
-
-
0025718710
-
Interactions between ascorbic acid and the radiation of bone marrow, skin, and tumor
-
Okunieff P. Interactions between ascorbic acid and the radiation of bone marrow, skin, and tumor. Am J Clin Nutr 1991;54:1281S-1283S.
-
(1991)
Am J Clin Nutr
, vol.54
-
-
Okunieff, P.1
-
70
-
-
0023250823
-
Toxicity, radiation sensitivity modification, and combined drug effects of ascorbic acid with misonidazole in vivo on FSall murine fibrosarcomas
-
Okunieff P, Suit HD. Toxicity, radiation sensitivity modification, and combined drug effects of ascorbic acid with misonidazole in vivo on FSall murine fibrosarcomas. J Natl Cancer Inst 1987;79:377-381.
-
(1987)
J Natl Cancer Inst
, vol.79
, pp. 377-381
-
-
Okunieff, P.1
Suit, H.D.2
-
71
-
-
0000610099
-
The influence of ascorbic acid on the growth of solid tumors in mice and on tumor control by X-irradiation
-
Tewfik FA, Tewfik HH, Riley EF. The influence of ascorbic acid on the growth of solid tumors in mice and on tumor control by X-irradiation. Int J Vitam Nutr Res Suppl 1982;23:257-263.
-
(1982)
Int J Vitam Nutr Res Suppl
, vol.23
, pp. 257-263
-
-
Tewfik, F.A.1
Tewfik, H.H.2
Riley, E.F.3
-
72
-
-
0023736564
-
Vitamin C and cancer
-
Hanck AB. Vitamin C and cancer. Prog Clin Biol Res 1988;259:301-320.
-
(1988)
Prog Clin Biol Res
, vol.259
, pp. 301-320
-
-
Hanck, A.B.1
-
73
-
-
0027277108
-
A double-blind, randomized, prospective trial to evaluate topical vitamin C solution for the prevention of radiation dermatitis
-
Halperin EC, Gaspar L, George S, et al. A double-blind, randomized, prospective trial to evaluate topical vitamin C solution for the prevention of radiation dermatitis. Int J Rad Oncol Biol Phys 1993;26:413-416.
-
(1993)
Int J Rad Oncol Biol Phys
, vol.26
, pp. 413-416
-
-
Halperin, E.C.1
Gaspar, L.2
George, S.3
-
74
-
-
0028911797
-
Ascorbic acid and cell survival of adriamycin resistant and sensitive MCF-7 breast tumor cells
-
Wells WW, Rocque PA, Xu DP. Ascorbic acid and cell survival of adriamycin resistant and sensitive MCF-7 breast tumor cells. Free Rad Biol Med 1995;18:699-708.
-
(1995)
Free Rad Biol Med
, vol.18
, pp. 699-708
-
-
Wells, W.W.1
Rocque, P.A.2
Xu, D.P.3
-
75
-
-
0029986515
-
Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro
-
Kurbacher CM, Wagner U, Kolster B, et al. Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro. Cancer Lett 1996;103:183-189.
-
(1996)
Cancer Lett
, vol.103
, pp. 183-189
-
-
Kurbacher, C.M.1
Wagner, U.2
Kolster, B.3
-
76
-
-
0028131244
-
Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells
-
Chiang CD, Song EJ, Yang VC, Chao CCK. Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells. Biochem J 1994;301:759-764.
-
(1994)
Biochem J
, vol.301
, pp. 759-764
-
-
Chiang, C.D.1
Song, E.J.2
Yang, V.C.3
Chao, C.C.K.4
-
77
-
-
0029005530
-
Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: Role for transforming growth factor beta
-
Turley JM, Funakoshi S, Ruscetti FW, et al. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor beta. Cell Growth Differ 1995;6:655-663.
-
(1995)
Cell Growth Differ
, vol.6
, pp. 655-663
-
-
Turley, J.M.1
Funakoshi, S.2
Ruscetti, F.W.3
-
78
-
-
0031025369
-
Vitamin E succinate induces Fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells
-
Turley JM, Fu TF, Ruscetti FW, et al. Vitamin E succinate induces Fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells. Cancer Res 1997;57:881-890.
-
(1997)
Cancer Res
, vol.57
, pp. 881-890
-
-
Turley, J.M.1
Fu, T.F.2
Ruscetti, F.W.3
-
79
-
-
0032951226
-
Biphasic action of vitamin E on the growth of human oral squamous carcinoma cells
-
Elattar TMA, Virji AS. Biphasic action of vitamin E on the growth of human oral squamous carcinoma cells. Anticancer Res 1999;19:365-368.
-
(1999)
Anticancer Res
, vol.19
, pp. 365-368
-
-
Elattar, T.M.A.1
Virji, A.S.2
-
80
-
-
0011165389
-
A phase I study of vitamin E and neuroblasoma
-
Prasad ed. New York: Karger Press
-
Helson L. A phase I study of vitamin E and neuroblasoma. In: Prasad ed. Vitamins, Nutrition, and Cancer. New York: Karger Press; 1984:274-281.
-
(1984)
Vitamins, Nutrition, and Cancer
, pp. 274-281
-
-
Helson, L.1
-
81
-
-
0031975234
-
Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy
-
Gogos CA, Ginopoulos P, Salsa B, et al. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy. Cancer 1998;82:395-402.
-
(1998)
Cancer
, vol.82
, pp. 395-402
-
-
Gogos, C.A.1
Ginopoulos, P.2
Salsa, B.3
-
83
-
-
0023721830
-
Safety of oral intake of vitamin E
-
Bendich A, Machlin LJ. Safety of oral intake of vitamin E. Am J Clin Nutr 1988;48:612-619.
-
(1988)
Am J Clin Nutr
, vol.48
, pp. 612-619
-
-
Bendich, A.1
Machlin, L.J.2
-
84
-
-
0015858990
-
Reduced effect of irradiation on normal and malignant cells irradiated in vivo in mice pretreated with vitamin E
-
Sakamoto K, Sakka M. Reduced effect of irradiation on normal and malignant cells irradiated in vivo in mice pretreated with vitamin E. Br J Radiology 1973;46:538-540.
-
(1973)
Br J Radiology
, vol.46
, pp. 538-540
-
-
Sakamoto, K.1
Sakka, M.2
-
85
-
-
0018088557
-
The effect of vitamin E on cellular survival after X irradiation of lymphoma cells
-
Fonck K, Konings AWT. The effect of vitamin E on cellular survival after X irradiation of lymphoma cells. Br J Radiology 1978;51:832-833.
-
(1978)
Br J Radiology
, vol.51
, pp. 832-833
-
-
Fonck, K.1
Konings, A.W.T.2
-
86
-
-
84907111289
-
Tocopherol in irradiation of experimental neoplasms
-
Kagreud A, Peterson HI. Tocopherol in irradiation of experimental neoplasms. Acta Radiol Oncol 1981;20:97-100.
-
(1981)
Acta Radiol Oncol
, vol.20
, pp. 97-100
-
-
Kagreud, A.1
Peterson, H.I.2
-
87
-
-
0031870092
-
Striking regression of radiation-induced fibrosis by a combination of pentoxifylline and tocopherol
-
Delanian S. Striking regression of radiation-induced fibrosis by a combination of pentoxifylline and tocopherol. Br J Radiology 1998;71:892-894.
-
(1998)
Br J Radiology
, vol.71
, pp. 892-894
-
-
Delanian, S.1
-
88
-
-
0018139881
-
Effect of alpha-tocopherol on the cardiotoxicity of adriamycin in the rat
-
Sonneveld R Effect of alpha-tocopherol on the cardiotoxicity of adriamycin in the rat. Cancer Treat Rep 1978;62:1033-1036.
-
(1978)
Cancer Treat Rep
, vol.62
, pp. 1033-1036
-
-
Sonneveld, R.1
-
89
-
-
0022515227
-
Vitamin E enhances the chemotherapeutic effects of adriamycin on human prostatic carcinoma cells in vitro
-
Perez Ripoll EA, Rama BN, Webber MM. Vitamin E enhances the chemotherapeutic effects of adriamycin on human prostatic carcinoma cells in vitro. J Urol 1986;136:529-531.
-
(1986)
J Urol
, vol.136
, pp. 529-531
-
-
Perez Ripoll, E.A.1
Rama, B.N.2
Webber, M.M.3
-
90
-
-
0023709436
-
Combined effects of vitamin E (alpha-tocopherol) and cisplatin on the growth of murine neuroblastoma in vivo
-
Sue K, Nakagawara A, Okuzono SI, et al. Combined effects of vitamin E (alpha-tocopherol) and cisplatin on the growth of murine neuroblastoma in vivo. Eur J Cancer Clin Oncol 1988;24:1751-1758.
-
(1988)
Eur J Cancer Clin Oncol
, vol.24
, pp. 1751-1758
-
-
Sue, K.1
Nakagawara, A.2
Okuzono, S.I.3
-
91
-
-
13044292888
-
Some remarks on the treatment of cancerous growths with selenium compounds
-
von Oefele F. Some remarks on the treatment of cancerous growths with selenium compounds. American Medicine 1912;18:216-219.
-
(1912)
American Medicine
, vol.18
, pp. 216-219
-
-
Von Oefele, F.1
-
92
-
-
0020046780
-
Effect of selenium on growth rate of canine mammary carcinoma cells in athymic nude mice
-
Watrach AM, Milner JA, Watrach MA. Effect of selenium on growth rate of canine mammary carcinoma cells in athymic nude mice. Cancer Lett 1982;15:137-143.
-
(1982)
Cancer Lett
, vol.15
, pp. 137-143
-
-
Watrach, A.M.1
Milner, J.A.2
Watrach, M.A.3
-
94
-
-
0031860004
-
Symptomatic treatment of brain tumor patients with sodium selenite, oxygen, and other supportive measures
-
Pakdaman A. Symptomatic treatment of brain tumor patients with sodium selenite, oxygen, and other supportive measures. Biol Trace Elem Res 1998;62:1-6.
-
(1998)
Biol Trace Elem Res
, vol.62
, pp. 1-6
-
-
Pakdaman, A.1
-
95
-
-
0024438952
-
The potential of selenium in the treatment of cancer
-
Ladas HS. The potential of selenium in the treatment of cancer. Holistic Med 1989;4:145-156.
-
(1989)
Holistic Med
, vol.4
, pp. 145-156
-
-
Ladas, H.S.1
-
96
-
-
0030774730
-
Role of sodium selenite as an adjuvant in radiotherapy of rectal carcinoma
-
Hehr T,Hoffmann W, Bamberg M. Role of sodium selenite as an adjuvant in radiotherapy of rectal carcinoma. Med Klin 1997;92:S48-S49.
-
(1997)
Med Klin
, vol.92
-
-
Hehr, T.1
Hoffmann, W.2
Bamberg, M.3
-
97
-
-
0020334081
-
Effect of tocopherol and selenium on defenses against reactive oxygen species and their effect on radiation sensitivity
-
Myers C, Katki A, Travis E. Effect of tocopherol and selenium on defenses against reactive oxygen species and their effect on radiation sensitivity. Ann NY Acad Sci 1982;393:419-425.
-
(1982)
Ann NY Acad Sci
, vol.393
, pp. 419-425
-
-
Myers, C.1
Katki, A.2
Travis, E.3
-
98
-
-
0023807284
-
The effects of co-administration of selenium and cis-platin (CDDP) on CDDP-induced toxicity and antitumor activity
-
Ohkawa K, Tsukada Y, Dohzono H, et al. The effects of co-administration of selenium and cis-platin (CDDP) on CDDP-induced toxicity and antitumor activity. Br J Cancer 1988;58:38-41.
-
(1988)
Br J Cancer
, vol.58
, pp. 38-41
-
-
Ohkawa, K.1
Tsukada, Y.2
Dohzono, H.3
-
99
-
-
8244221011
-
The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients
-
Hu YJ, Chen Y, Zhang YQ, et al. The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients. Biol Trace Elem Res 1997;56:331-341.
-
(1997)
Biol Trace Elem Res
, vol.56
, pp. 331-341
-
-
Hu, Y.J.1
Chen, Y.2
Zhang, Y.Q.3
-
100
-
-
0025106069
-
Inhibition of bleomycin-induced toxic effects by antioxidants in human malignant melanoma cells
-
Kappus H, Reinhold C. Inhibition of bleomycin-induced toxic effects by antioxidants in human malignant melanoma cells. Adv Exp Med Biol 1990;264:345-348.
-
(1990)
Adv Exp Med Biol
, vol.264
, pp. 345-348
-
-
Kappus, H.1
Reinhold, C.2
-
102
-
-
0029084539
-
Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases
-
Lockwood K, Moesgaard S, Yamamoto T, Folkers K. Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases. Biochem Biophys Res Comm 1995;212:172-177.
-
(1995)
Biochem Biophys Res Comm
, vol.212
, pp. 172-177
-
-
Lockwood, K.1
Moesgaard, S.2
Yamamoto, T.3
Folkers, K.4
-
103
-
-
0028609514
-
Apparent partial remission of breast cancer in 'high-risk' patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10
-
Lockwood K, Moesgaard S, Hanioka T, Folkers K. Apparent partial remission of breast cancer in 'high-risk' patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10. Molec Aspects Med 1994;15:S231-S240.
-
(1994)
Molec Aspects Med
, vol.15
-
-
Lockwood, K.1
Moesgaard, S.2
Hanioka, T.3
Folkers, K.4
-
105
-
-
0021227758
-
Investigation of the preventive effect of CoQ10 against the side-effects of anthracycline antineoplastic agents
-
Tsubaki K, Horiuchi A, Kitani T, et al. Investigation of the preventive effect of CoQ10 against the side-effects of anthracycline antineoplastic agents. Gan To Kagaku Ryoho 1984;11:1420-1427.
-
(1984)
Gan to Kagaku Ryoho
, vol.11
, pp. 1420-1427
-
-
Tsubaki, K.1
Horiuchi, A.2
Kitani, T.3
-
107
-
-
0028652328
-
Protective effect of coenzyme Q10 on anthracyclines cardiotoxicity: Control study in children with acute lymphoblastic leukemia and non-hodgkin lymphoma
-
Iarussi D, Auricchio U, Agretto A, et al. Protective effect of coenzyme Q10 on anthracyclines cardiotoxicity: control study in children with acute lymphoblastic leukemia and non-hodgkin lymphoma. Molec Aspects Med 1994;15:S207-S212.
-
(1994)
Molec Aspects Med
, vol.15
-
-
Iarussi, D.1
Auricchio, U.2
Agretto, A.3
-
108
-
-
0030752296
-
Melatonin in relation to cellular antioxidative defense mechanisms
-
Reiter RJ, Carneiro RC, Oh CS. Melatonin in relation to cellular antioxidative defense mechanisms. Horm Metab Res 1997;29:363-372.
-
(1997)
Horm Metab Res
, vol.29
, pp. 363-372
-
-
Reiter, R.J.1
Carneiro, R.C.2
Oh, C.S.3
-
109
-
-
0031987285
-
Clinical implications of p53: Effect on prognosis, tumor progression and chemotherapy response
-
Peller S. Clinical implications of p53: effect on prognosis, tumor progression and chemotherapy response. Semin Cancer Biol 1998;8:379-387.
-
(1998)
Semin Cancer Biol
, vol.8
, pp. 379-387
-
-
Peller, S.1
-
110
-
-
0031831115
-
Melatonin as biological response modifier in cancer patients
-
Neri B, DeLeonardis V, Gemelli MT, et al. Melatonin as biological response modifier in cancer patients. Anticancer Res 1998;18:1329-1332.
-
(1998)
Anticancer Res
, vol.18
, pp. 1329-1332
-
-
Neri, B.1
DeLeonardis, V.2
Gemelli, M.T.3
-
111
-
-
0030056686
-
Is there a role for melatonin in the treatment of neoplastic cachexia
-
Lissoni P, Paoorossi F, Tancini G, et al. Is there a role for melatonin in the treatment of neoplastic cachexia. Eur J Cancer 1996;32A:1340-1343.
-
(1996)
Eur J Cancer
, vol.32 A
, pp. 1340-1343
-
-
Lissoni, P.1
Paoorossi, F.2
Tancini, G.3
-
112
-
-
0026722527
-
Randomized study with the pineal hormone melatonin versus supportive care alone in advanced nonsmall cell lung cancer resistant to a first-line chemotherapy containing cisplatin
-
Lissoni P, Barni S, Ardizzoia A, et al. Randomized study with the pineal hormone melatonin versus supportive care alone in advanced nonsmall cell lung cancer resistant to a first-line chemotherapy containing cisplatin. Oncology 1992;49:336-339.
-
(1992)
Oncology
, vol.49
, pp. 336-339
-
-
Lissoni, P.1
Barni, S.2
Ardizzoia, A.3
-
113
-
-
0028156791
-
A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasms
-
Lissoni P, Barni S, Ardizzoia A, et al. A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasms. Cancer 1994;73:699-701.
-
(1994)
Cancer
, vol.73
, pp. 699-701
-
-
Lissoni, P.1
Barni, S.2
Ardizzoia, A.3
-
114
-
-
0030276855
-
Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma
-
Lissoni P, Brivio O, Brivio F, et al. Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma. J Pineal Res 1996;21:239-242.
-
(1996)
J Pineal Res
, vol.21
, pp. 239-242
-
-
Lissoni, P.1
Brivio, O.2
Brivio, F.3
-
115
-
-
0024358784
-
Endocrine and immune effects of melatonin therapy in metastatic cancer patients
-
Lissoni P, Barni S, Crispino S, et al. Endocrine and immune effects of melatonin therapy in metastatic cancer patients. Eur J Cancer Clin Oncol 1989;25:789-795.
-
(1989)
Eur J Cancer Clin Oncol
, vol.25
, pp. 789-795
-
-
Lissoni, P.1
Barni, S.2
Crispino, S.3
-
116
-
-
0033596580
-
Evaluation of an unconventional cancer treatment (the Di Bella multitherapy): Results of phase II trials in Italy
-
Italian Study Group for the Di Bella Multitherapy Trials
-
Anonymous. Evaluation of an unconventional cancer treatment (the Di Bella multitherapy): results of phase II trials in Italy. Italian Study Group for the Di Bella Multitherapy Trials. BMJ 1999;318:224-228.
-
(1999)
BMJ
, vol.318
, pp. 224-228
-
-
-
117
-
-
0033035371
-
Melatonin and protection from whole-body irradiation: Survival studies in mice
-
Vijayalaxmi R, Meltz ML, Reiter RJ, et al. Melatonin and protection from whole-body irradiation: survival studies in mice. Mutat Res 1999;425:21-27.
-
(1999)
Mutat Res
, vol.425
, pp. 21-27
-
-
Vijayalaxmi, R.1
Meltz, M.L.2
Reiter, R.J.3
-
118
-
-
0030025155
-
Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone
-
Lissoni P, Meregalli S, Nosetto L, et al. Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone. Oncology 1996;53:43-46.
-
(1996)
Oncology
, vol.53
, pp. 43-46
-
-
Lissoni, P.1
Meregalli, S.2
Nosetto, L.3
-
119
-
-
0029851134
-
A phase II study of tamoxifen plus melatonin in metastatic solid tumor patients
-
Lissoni P, Paolorossi F, Tancinin G, et al. A phase II study of tamoxifen plus melatonin in metastatic solid tumor patients. Br J Cancer 1996;74:1466-1468.
-
(1996)
Br J Cancer
, vol.74
, pp. 1466-1468
-
-
Lissoni, P.1
Paolorossi, F.2
Tancinin, G.3
-
120
-
-
0032934895
-
Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: A phase II study
-
Lissoni P, Tancini G, Paolorossi F, et al. Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: a phase II study. J Pineal Res 1999;26:169-173.
-
(1999)
J Pineal Res
, vol.26
, pp. 169-173
-
-
Lissoni, P.1
Tancini, G.2
Paolorossi, F.3
-
121
-
-
0031202122
-
A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state
-
Lissoni P, Paolorossi F, Ardizzoia A. A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state. J Pineal Res 1997;23:15-19.
-
(1997)
J Pineal Res
, vol.23
, pp. 15-19
-
-
Lissoni, P.1
Paolorossi, F.2
Ardizzoia, A.3
-
122
-
-
0032903822
-
Double-blind randomized study on the myeloprotective effect of melatonin in combination with carboplatin and etoposide in advanced lung cancer
-
Ghielmini M, Pagani O, de Jong J. Double-blind randomized study on the myeloprotective effect of melatonin in combination with carboplatin and etoposide in advanced lung cancer. Br J Cancer 1999;80:1058-1061.
-
(1999)
Br J Cancer
, vol.80
, pp. 1058-1061
-
-
Ghielmini, M.1
Pagani, O.2
De Jong, J.3
-
123
-
-
0028115805
-
A randomized study with subcutaneous low-dose interleukin 2 alone vs. interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma
-
Lissoni P, Barni S, Tancini G. A randomized study with subcutaneous low-dose interleukin 2 alone vs. interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma. Br J Cancer 1994;69:196-199.
-
(1994)
Br J Cancer
, vol.69
, pp. 196-199
-
-
Lissoni, P.1
Barni, S.2
Tancini, G.3
-
124
-
-
0028626331
-
A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs. chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancer
-
Lissoni P, Meregalli S, Fossati V, et al. A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs. chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancer. Tumori 1994;80:464-467.
-
(1994)
Tumori
, vol.80
, pp. 464-467
-
-
Lissoni, P.1
Meregalli, S.2
Fossati, V.3
-
125
-
-
0020535852
-
Clinical safety of high oral doses of acetylcysteine
-
Miller LF, Rumack BH. Clinical safety of high oral doses of acetylcysteine. Sem Oncol 1983;10:S76-S85.
-
(1983)
Sem Oncol
, vol.10
-
-
Miller, L.F.1
Rumack, B.H.2
-
126
-
-
0026461046
-
N-Acetylcystine in combination with radiotherapy in the treatment of non-small cell lung cancer: A feasibility study
-
Maasilta P, Holsti LR, Blomqvist P, et al. N-Acetylcystine in combination with radiotherapy in the treatment of non-small cell lung cancer: a feasibility study. Radiother Oncol 1992;25:192-195.
-
(1992)
Radiother Oncol
, vol.25
, pp. 192-195
-
-
Maasilta, P.1
Holsti, L.R.2
Blomqvist, P.3
-
127
-
-
0024390065
-
Effect of N-acetylcysteine on the antiproliferative action of X-rays or bleomycin in cultured human lung cancer cells
-
Wanamarta AH, van Rijn J, Blank LECM, et al. Effect of N-acetylcysteine on the antiproliferative action of X-rays or bleomycin in cultured human lung cancer cells. J Cancer Res Clin Oncol 1989;115:340-344.
-
(1989)
J Cancer Res Clin Oncol
, vol.115
, pp. 340-344
-
-
Wanamarta, A.H.1
Van Rijn, J.2
Blank, L.E.C.M.3
-
128
-
-
0020638928
-
Topical use of N-acetylcysteine for reduction of skin reaction to radiation therapy
-
Kim JA, Baker DG, Hahn SS, et al. Topical use of N-acetylcysteine for reduction of skin reaction to radiation therapy. Sem Oncol 1983;10:S86-S88.
-
(1983)
Sem Oncol
, vol.10
-
-
Kim, J.A.1
Baker, D.G.2
Hahn, S.S.3
-
129
-
-
0020537159
-
The effect of N-acetylcysteine on cyclophosphamide immunoregulation and antitumor activity
-
Levy L, Vredevoe DL. The effect of N-acetylcysteine on cyclophosphamide immunoregulation and antitumor activity. Semin Oncol 1983;10:S7-S16.
-
(1983)
Semin Oncol
, vol.10
-
-
Levy, L.1
Vredevoe, D.L.2
-
130
-
-
0020541338
-
Effect of N-acetylcysteine on the antitumor activity of cyclophosphamide against Walker-256 carcinosarcoma in rats
-
Harrison EF, Fuquay ME, Hunter HL. Effect of N-acetylcysteine on the antitumor activity of cyclophosphamide against Walker-256 carcinosarcoma in rats. Semin Oncol 1983;10:S25-S27.
-
(1983)
Semin Oncol
, vol.10
-
-
Harrison, E.F.1
Fuquay, M.E.2
Hunter, H.L.3
-
131
-
-
0022551494
-
Immunomodulation exerted by cyclophosphamide is not interfered with by N-acetylcysteine
-
Palermo MS, Olabuenaga SE, Giordano M, Isturiz MA. Immunomodulation exerted by cyclophosphamide is not interfered with by N-acetylcysteine. Int J Immunopharmac 1986;8:651-655.
-
(1986)
Int J Immunopharmac
, vol.8
, pp. 651-655
-
-
Palermo, M.S.1
Olabuenaga, S.E.2
Giordano, M.3
Isturiz, M.A.4
-
132
-
-
0020957852
-
Phase I clinical study of acetylcysteine's preventing ifosfamide-induced hematuria
-
Slavik M, Saiers JH. Phase I clinical study of acetylcysteine's preventing ifosfamide-induced hematuria. Semin Oncol 1983;10:S62-S65.
-
(1983)
Semin Oncol
, vol.10
-
-
Slavik, M.1
Saiers, J.H.2
-
133
-
-
0020537163
-
Prophylaxis of ifosfamide toxicity with oral acetylcysteine
-
Holoye PY, Duelge J, Hansen RM, et al. Prophylaxis of ifosfamide toxicity with oral acetylcysteine. Semin Oncol 1983;10:S66-S71.
-
(1983)
Semin Oncol
, vol.10
-
-
Holoye, P.Y.1
Duelge, J.2
Hansen, R.M.3
-
134
-
-
0020583667
-
A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine
-
Myers C, Bonow R, Palmeri S, et al. A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine. Semin Oncol 1983;10:S53-S55.
-
(1983)
Semin Oncol
, vol.10
-
-
Myers, C.1
Bonow, R.2
Palmeri, S.3
-
135
-
-
0021068742
-
Attempt to prevent doxorubicin induced acute human myocardial morphologic damage with acetylcysteine
-
Unverferth DV, Jagadeesh JM, Unverferth BJ, et al. Attempt to prevent doxorubicin induced acute human myocardial morphologic damage with acetylcysteine. J Natl Cancer Inst 1983;71:917-920.
-
(1983)
J Natl Cancer Inst
, vol.71
, pp. 917-920
-
-
Unverferth, D.V.1
Jagadeesh, J.M.2
Unverferth, B.J.3
-
136
-
-
0020615815
-
Influence of N-acetylcysteine on the antitumor activity of doxorubicin
-
Olson RD, Stroo WE, Boerth RC. Influence of N-acetylcysteine on the antitumor activity of doxorubicin. Semin Oncol 1983;10:S29-S34.
-
(1983)
Semin Oncol
, vol.10
-
-
Olson, R.D.1
Stroo, W.E.2
Boerth, R.C.3
-
137
-
-
0022542305
-
Prevention of adriamycin cardiotoxicity by niacin, isocitrate, or N-acetylcysteine in mice
-
Schmitt-Graff A, Scheulen ME. Prevention of adriamycin cardiotoxicity by niacin, isocitrate, or N-acetylcysteine in mice. Path Res Pract 1986;181:168-174.
-
(1986)
Path Res Pract
, vol.181
, pp. 168-174
-
-
Schmitt-Graff, A.1
Scheulen, M.E.2
-
138
-
-
0032425714
-
Antioxidants specifically inhibit cisplatin cytotoxicity of human malignant glioma cells
-
Roller A, Weller M. Antioxidants specifically inhibit cisplatin cytotoxicity of human malignant glioma cells. Anticancer Res 1998;18:4493-4497.
-
(1998)
Anticancer Res
, vol.18
, pp. 4493-4497
-
-
Roller, A.1
Weller, M.2
-
139
-
-
0032999585
-
N-acetylcysteine modifies cis-dichlorodiammineplatinum induced effects in bladder cancer cells
-
Miyajima A, Nakashima J, Tachibana M, et al. N-acetylcysteine modifies cis-dichlorodiammineplatinum induced effects in bladder cancer cells. Jpn J Cancer Res 1999;90:565-570.
-
(1999)
Jpn J Cancer Res
, vol.90
, pp. 565-570
-
-
Miyajima, A.1
Nakashima, J.2
Tachibana, M.3
-
140
-
-
0030720871
-
Cisplatin-induced renal toxicity: Possible reversal by N-acetylcysteine treatment
-
Sheikh-Hamad D, Timmins K, Jalali Z. Cisplatin-induced renal toxicity: possible reversal by N-acetylcysteine treatment. J Am Soc Nephrol 1997;8:1640-1644.
-
(1997)
J Am Soc Nephrol
, vol.8
, pp. 1640-1644
-
-
Sheikh-Hamad, D.1
Timmins, K.2
Jalali, Z.3
-
142
-
-
0025155281
-
Bioavailability of dietary glutathione: Effect on plasma concentration
-
Hagen TM, Wierzbicka GT, Sillau AH, et al. Bioavailability of dietary glutathione: effect on plasma concentration. Am J Physiol 1990;259:G524-G529.
-
(1990)
Am J Physiol
, vol.259
-
-
Hagen, T.M.1
Wierzbicka, G.T.2
Sillau, A.H.3
-
143
-
-
0027486588
-
Correction of glutathione deficiency in the lower respiratory tract of HIV seropositive individuals by glutathione aerosol treatment
-
Holroyd KJ, Buhl R, Borok Z, et al. Correction of glutathione deficiency in the lower respiratory tract of HIV seropositive individuals by glutathione aerosol treatment. Thorax 1993;48:985-989.
-
(1993)
Thorax
, vol.48
, pp. 985-989
-
-
Holroyd, K.J.1
Buhl, R.2
Borok, Z.3
-
144
-
-
0032923938
-
The sulfhydryl containing compounds WR-2721 and glutathione as radio- And chemoprotective agents. A review, indications for use and prospects
-
Hospers GAP, Eisenhauer EA, de Vries EGE. The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects. Br J Cancer 1999;80:629-638.
-
(1999)
Br J Cancer
, vol.80
, pp. 629-638
-
-
Hospers, G.A.P.1
Eisenhauer, E.A.2
De Vries, E.G.E.3
-
145
-
-
0026441505
-
Glutathione treatment of hepatocellular carcinoma
-
Dalhoff K, Ranek L, Mantoni M, Poulsen, HE. Glutathione treatment of hepatocellular carcinoma. Liver 1992;12:341-343.
-
(1992)
Liver
, vol.12
, pp. 341-343
-
-
Dalhoff, K.1
Ranek, L.2
Mantoni, M.3
Poulsen, H.E.4
-
146
-
-
0019394120
-
Regression of aflatoxin B1-induced hepatocellular carcinomas by reduced glutathione
-
Novi AM. Regression of aflatoxin B1-induced hepatocellular carcinomas by reduced glutathione. Science 1981;212:541-542.
-
(1981)
Science
, vol.212
, pp. 541-542
-
-
Novi, A.M.1
-
147
-
-
0000320310
-
Glutathione: Systemic protectant against oxidative and free radical damage
-
Kidd PM. Glutathione: systemic protectant against oxidative and free radical damage. Altern Med Rev 1997;2:155-176.
-
(1997)
Altern Med Rev
, vol.2
, pp. 155-176
-
-
Kidd, P.M.1
-
148
-
-
0027004540
-
Adjuvant radiotherapy of the pelvis with or without reduced glutathione: A randomized trial in patients operated on for endometrial cancer
-
DeMaria D, Falchi AM, Venturino P. Adjuvant radiotherapy of the pelvis with or without reduced glutathione: a randomized trial in patients operated on for endometrial cancer. Tumori 1992;78:374-376.
-
(1992)
Tumori
, vol.78
, pp. 374-376
-
-
Demaria, D.1
Falchi, A.M.2
Venturino, P.3
-
149
-
-
0025569131
-
The role of detoxifying systems in resistance of tumor cells to cisplatin and adriamycin
-
Meijer C, Mulder NH, de Vries EGE. The role of detoxifying systems in resistance of tumor cells to cisplatin and adriamycin. Cancer Treat Rev 1990;17:389-407.
-
(1990)
Cancer Treat Rev
, vol.17
, pp. 389-407
-
-
Meijer, C.1
Mulder, N.H.2
De Vries, E.G.E.3
-
150
-
-
0031158107
-
Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: Results of a double-blind, randomised trial
-
Smyth JF, Bowman A, Parren T, et al. Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial. Ann Oncol 1997;8:569-573.
-
(1997)
Ann Oncol
, vol.8
, pp. 569-573
-
-
Smyth, J.F.1
Bowman, A.2
Parren, T.3
-
151
-
-
0029775775
-
Neurotoxicity of cisplatin +/- Reduced glutathione in the first-line treatment of advanced ovarian cancer
-
Bogliun G, Marzorati L, Marzola M, et al. Neurotoxicity of cisplatin +/- reduced glutathione in the first-line treatment of advanced ovarian cancer. Int J Gynaecol Cancer 1996;6:415-419.
-
(1996)
Int J Gynaecol Cancer
, vol.6
, pp. 415-419
-
-
Bogliun, G.1
Marzorati, L.2
Marzola, M.3
-
152
-
-
0028815902
-
Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: A randomized double-blind placebo-controlled trial
-
Cascinu S, Cordelia L, Del Ferro E, et al. Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial. J Clin Oncol 1995;13:26-32.
-
(1995)
J Clin Oncol
, vol.13
, pp. 26-32
-
-
Cascinu, S.1
Cordelia, L.2
Del Ferro, E.3
-
153
-
-
0027508807
-
High-dose cisplatin and cyclophosphamide with glutathione in the treatment of advanced ovarian cancer
-
Di Re F, Bohm S, Oriana S, et al. High-dose cisplatin and cyclophosphamide with glutathione in the treatment of advanced ovarian cancer. Ann Oncol 1993;4:55-61.
-
(1993)
Ann Oncol
, vol.4
, pp. 55-61
-
-
Di Re, F.1
Bohm, S.2
Oriana, S.3
-
154
-
-
0027151989
-
A phase II study of combination chemotherapy in advanced ovarian carcinoma with cisplatin and cyclophosphamide plus reduced glutathione as potential protective agent against cisplatin toxicity
-
Locatelli MC, D'Antonia A, Lablanca R, et al. A phase II study of combination chemotherapy in advanced ovarian carcinoma with cisplatin and cyclophosphamide plus reduced glutathione as potential protective agent against cisplatin toxicity. Tumori 1993;79:37-39.
-
(1993)
Tumori
, vol.79
, pp. 37-39
-
-
Locatelli, M.C.1
D'Antonia, A.2
Lablanca, R.3
-
155
-
-
0031788509
-
Green tea and cancer in humans: A review of the literature
-
Bushman JL: Green tea and cancer in humans: a review of the literature. Nutr Cancer 1998;31:151-159.
-
(1998)
Nutr Cancer
, vol.31
, pp. 151-159
-
-
Bushman, J.L.1
-
156
-
-
0032970710
-
P-53-independent apoptosis induced by genestein in lung cancer cells
-
Lian F, Li Y, Bhuiyan M, Sarkar FH. P-53-independent apoptosis induced by genestein in lung cancer cells. Nutr Cancer 1999;33:125-131.
-
(1999)
Nutr Cancer
, vol.33
, pp. 125-131
-
-
Lian, F.1
Li, Y.2
Bhuiyan, M.3
Sarkar, F.H.4
-
157
-
-
0033036785
-
The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function
-
Miodini P, Fioravanti L, DiFronzo G, Cappelletti V. The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function. Br J Cancer 1999;80:1150-1155.
-
(1999)
Br J Cancer
, vol.80
, pp. 1150-1155
-
-
Miodini, P.1
Fioravanti, L.2
DiFronzo, G.3
Cappelletti, V.4
-
158
-
-
0033106247
-
Dietary curcumin with cisplatin administration modulates tumour marker indices in experimental fibrosarcoma
-
Sriganth INP, Premalatha B. Dietary curcumin with cisplatin administration modulates tumour marker indices in experimental fibrosarcoma. Pharmacol Res 1999;39:175-179.
-
(1999)
Pharmacol Res
, vol.39
, pp. 175-179
-
-
Sriganth, I.N.P.1
Premalatha, B.2
-
159
-
-
0033594891
-
Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: Implications for prostate cancer intervention
-
Zi X, Agarwal R. Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention. Proc Natl Acad Sci 1999;96:7490-7495.
-
(1999)
Proc Natl Acad Sci
, vol.96
, pp. 7490-7495
-
-
Zi, X.1
Agarwal, R.2
-
160
-
-
0030751337
-
Flavonoids as enhancers of x-ray-induced cell damage in hepatoma cells
-
van Rijn J, van den Berg J. Flavonoids as enhancers of x-ray-induced cell damage in hepatoma cells. Clin Cancer Res 1997;3:1775-1779.
-
(1997)
Clin Cancer Res
, vol.3
, pp. 1775-1779
-
-
Van Rijn, J.1
Van Den Berg, J.2
-
161
-
-
0017645173
-
Rutosides and radiation induced regression of experimental tumors
-
Fritz-Niggli H, Rao KR. Rutosides and radiation induced regression of experimental tumors. Arzn Forsch 1977;27:1057-1064.
-
(1977)
Arzn Forsch
, vol.27
, pp. 1057-1064
-
-
Fritz-Niggli, H.1
Rao, K.R.2
-
162
-
-
0033006305
-
Multidrug resistance in oncology: Diagnostic and therapeutic approaches
-
Robert J. Multidrug resistance in oncology: diagnostic and therapeutic approaches. Eur J Clin Invest 1999;29:536-545.
-
(1999)
Eur J Clin Invest
, vol.29
, pp. 536-545
-
-
Robert, J.1
-
164
-
-
0032433184
-
Enhancing effects of green tea components on the antitumor activity of adriamycin against M5076 ovarian sarcoma
-
Sugiyama T, Sadzuka Y. Enhancing effects of green tea components on the antitumor activity of adriamycin against M5076 ovarian sarcoma. Cancer Lett 1998;133:19-26.
-
(1998)
Cancer Lett
, vol.133
, pp. 19-26
-
-
Sugiyama, T.1
Sadzuka, Y.2
-
165
-
-
0027981909
-
Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast cancer cell line: P-glycoprotein as a possible target
-
Scambia G, Ranelletti FO, Panici PB, et al. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast cancer cell line: P-glycoprotein as a possible target. Cancer Chemother Pharmacol 1994;34:459-464.
-
(1994)
Cancer Chemother Pharmacol
, vol.34
, pp. 459-464
-
-
Scambia, G.1
Ranelletti, F.O.2
Panici, P.B.3
-
166
-
-
0028172728
-
Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells
-
Critchfield JW, Welsh CJ, Phang JM, Yeh GC. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Biochem Pharm 1994;48:1437-1445.
-
(1994)
Biochem Pharm
, vol.48
, pp. 1437-1445
-
-
Critchfield, J.W.1
Welsh, C.J.2
Phang, J.M.3
Yeh, G.C.4
-
167
-
-
0027482403
-
Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells
-
Versantvoort CHM, Schuurhuis GJ, Pinedo HM, et al. Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells. Br J Cancer 1993;68:939-946.
-
(1993)
Br J Cancer
, vol.68
, pp. 939-946
-
-
Versantvoort, C.H.M.1
Schuurhuis, G.J.2
Pinedo, H.M.3
-
168
-
-
0029934208
-
Stimulation of cis-diamminedichloroplatinum(II) accumulation by modulation of passive permeability with genistein: An altered response in accumulation-defective resistant cells
-
Marverti G, Andrews PA. Stimulation of cis-diamminedichloroplatinum(II) accumulation by modulation of passive permeability with genistein: an altered response in accumulation-defective resistant cells. Clin Cancer Res 1996;2:991-999.
-
(1996)
Clin Cancer Res
, vol.2
, pp. 991-999
-
-
Marverti, G.1
Andrews, P.A.2
-
169
-
-
0025239010
-
Enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by quercetin
-
Hofmann J, Fiebig HH, Winterhalter BR, et al. Enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by quercetin. Int J Cancer 1990;45:536-539.
-
(1990)
Int J Cancer
, vol.45
, pp. 536-539
-
-
Hofmann, J.1
Fiebig, H.H.2
Winterhalter, B.R.3
-
170
-
-
0026773296
-
Inhibitory effect of quercetin on primary ovarian and endometrial cancers and synergistic activity with cis-diamminedichloroplatinum (II)
-
Scambia G, Ranelletti FO, Panici PB, et al. Inhibitory effect of quercetin on primary ovarian and endometrial cancers and synergistic activity with cis-diamminedichloroplatinum (II). Gynecol Oncol 1992;45:13-19.
-
(1992)
Gynecol Oncol
, vol.45
, pp. 13-19
-
-
Scambia, G.1
Ranelletti, F.O.2
Panici, P.B.3
-
171
-
-
0033577042
-
Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer
-
Bracke ME, Depypere HT, Boterberg T, et al. Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer. J Natl Cancer Inst 1999;91:354-359.
-
(1999)
J Natl Cancer Inst
, vol.91
, pp. 354-359
-
-
Bracke, M.E.1
Depypere, H.T.2
Boterberg, T.3
-
172
-
-
0032501394
-
Genistein-mediated attenuation of tamoxifen-induced antagonism from estrogen receptor-regulated genes
-
Schwartz JA, Liu G, Brooks SC. Genistein-mediated attenuation of tamoxifen-induced antagonism from estrogen receptor-regulated genes. Bioch Biophys Res Comm 1998;253:38-43.
-
(1998)
Bioch Biophys Res Comm
, vol.253
, pp. 38-43
-
-
Schwartz, J.A.1
Liu, G.2
Brooks, S.C.3
-
173
-
-
0032781422
-
Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells
-
Shen F, Xue X, Weber G. Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells. Anticancer Res 1999;19:1657-1662.
-
(1999)
Anticancer Res
, vol.19
, pp. 1657-1662
-
-
Shen, F.1
Xue, X.2
Weber, G.3
-
174
-
-
0024447349
-
Regression of experimental cancer by oral administration of combined alpha-tocopherol and beta-carotene
-
Shklar G, Schwartz J, Trickler D, Reid S. Regression of experimental cancer by oral administration of combined alpha-tocopherol and beta-carotene. Nutr Cancer 1989;12:321-325.
-
(1989)
Nutr Cancer
, vol.12
, pp. 321-325
-
-
Shklar, G.1
Schwartz, J.2
Trickler, D.3
Reid, S.4
-
175
-
-
0030054863
-
Cardioprotection in patients undergoing chemo- And/or radiotherapy for neoplastic disease
-
Wagdi P, Fluri M, Aeschbacher B, et al. Cardioprotection in patients undergoing chemo- and/or radiotherapy for neoplastic disease. Jpn Heart J 1996;37:353-359.
-
(1996)
Jpn Heart J
, vol.37
, pp. 353-359
-
-
Wagdi, P.1
Fluri, M.2
Aeschbacher, B.3
-
176
-
-
0025764913
-
Medical oncology in the 1990's
-
Braverman A. Medical oncology in the 1990's. Lancet 1991;337:901-902.
-
(1991)
Lancet
, vol.337
, pp. 901-902
-
-
Braverman, A.1
-
177
-
-
13044265321
-
Chemotherapeutic failure: Resistance or insensitivity?
-
Braverman A. Chemotherapeutic failure: resistance or insensitivity? Lancet 1980;2:1343-1346.
-
(1980)
Lancet
, vol.2
, pp. 1343-1346
-
-
Braverman, A.1
-
178
-
-
0016688277
-
The vitamin fraud in cancer quackery
-
Greenberg DM. The vitamin fraud in cancer quackery. West J Med 1975;122:345-348.
-
(1975)
West J Med
, vol.122
, pp. 345-348
-
-
Greenberg, D.M.1
-
179
-
-
0014442953
-
Synergistic killing of Ehrlich ascites carcinoma cells by ascorbate and 3-amino-1,2,4,-triazole
-
Benade L, Howard T, Burk D. Synergistic killing of Ehrlich ascites carcinoma cells by ascorbate and 3-amino-1,2,4,-triazole. Oncology 1969;23:33-43.
-
(1969)
Oncology
, vol.23
, pp. 33-43
-
-
Benade, L.1
Howard, T.2
Burk, D.3
|